The Alliance is guided by a Scientific Advisory Committee made up of 12 radiation oncologists representing a variety of specialties and proton centers from across the country to advise the Alliance on research developments to support its advocacy programs.
As long as cancer patients and families across the country continue to face treatment delays and denials for proton therapy, the Alliance will seek increased transparency and fairness in the insurance decision-making process. "We look forward to working with patients, their families and caregivers, physicians and others in the proton community to ensure patients aren't turned down when proton therapy is their best shot at beating cancer and enjoying the highest quality of life," concluded Smith.
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About The Alliance
The Alliance for Proton Therapy Access is an advocacy organization comprised of a growing community of patients, families, caregivers, physicians and industry partners working together to make sure all cancer patients seeking proton therapy receive fair and timely payment decisions from their health insurers.
The Alliance is governed by a Board of Directors made up of patients, physicians and industry partners. A Scientific Advisory Committee of leading physician experts from across the proton community provides guidance. Sign up to be an advocate and learn more about the Alliance at allianceforprotontherapy.org. Follow the Alliance on Facebook And Twitter and join the conversation at #FightCancerNotMe.
SOURCE Alliance for Proton Therapy Access
Back to HCB News
